Background
==========

Congenital heart disease (CHD), which arises from defective cardiac structure, has a global incidence of approximately 1% \[[@b1-medscimonit-26-e925388]\]. Individuals with CHD are at risk for heart failure and arrhythmias \[[@b2-medscimonit-26-e925388]\]. Common types of CHD include atrial septal defect (ASD), ventricular septal defect (VSD), patent ductus arteriosus, and tetralogy of Fallot \[[@b3-medscimonit-26-e925388]\], with ASD and VSD being the most common types \[[@b4-medscimonit-26-e925388]\]. ASD is a continuous interruption of the cardiac atrial septum, which can lead to heart failure, arrhythmia, and pulmonary hypertension. Among possible pathogenic factors leading to CHD \[[@b5-medscimonit-26-e925388], [@b6-medscimonit-26-e925388]\], genetic factors, especially abnormalities of *NKX2--5* \[[@b4-medscimonit-26-e925388]\], are considered to be associated with the disease, especially with ASD \[[@b7-medscimonit-26-e925388]\].

Human *NKX2--5*, located at chromosome 5q35.1, consists of 3213 bases, including 3 exons. Through alternative splicing, 3 isoforms are possible \[[@b8-medscimonit-26-e925388]\]. All 3 isoforms are expressed in the heart, with isoform 1, which contains the homeodomain, being the most abundant \[[@b8-medscimonit-26-e925388]\]. Isoforms 2 and 3 lack the homeodomain \[[@b8-medscimonit-26-e925388]\]. Human NKX2--5 consists of 324 amino acids and contains several functional domains, including the HD domain, which has a role in DNA binding and activation of transcription \[[@b9-medscimonit-26-e925388],[@b10-medscimonit-26-e925388]\]; the NK2-specific domain, which helps to regulate the transcriptional activation of NK-2-class proteins \[[@b11-medscimonit-26-e925388]\]; and the nuclear localization signal, which is involved in the phosphorylation of NKX2--5 \[[@b12-medscimonit-26-e925388]\]. NKX2--5 is conserved in mammals \[[@b13-medscimonit-26-e925388]\] and functions in the morphogenesis of the heart \[[@b14-medscimonit-26-e925388],[@b15-medscimonit-26-e925388]\]. In mice, disruption *of Nkx2--5* has been associated with arrhythmias, abnormal myocardial contraction, abnormal cardiac morphogenesis, and death \[[@b16-medscimonit-26-e925388]\]. Notably, the structural abnormalities of the hearts of these mice are highly similar to those of patients with CHD \[[@b16-medscimonit-26-e925388],[@b17-medscimonit-26-e925388]\]. Therefore, we hypothesized that mutations in *NKX2--5* are related to CHD.

Our study relied in part on miRNAs, which are noncoding RNAs that are highly evolutionarily conserved \[[@b18-medscimonit-26-e925388]\]. miRNAs can bind to mRNA to inhibit the expression of a target gene \[[@b19-medscimonit-26-e925388],[@b20-medscimonit-26-e925388]\].

In our study, we knocked down the *Nkx2--5* gene in H9c2 cells and investigated the changes in cell proliferation, migration, and the transcripts to clarify the function and mechanisms of NKX2--5 in the heart.

Material and Methods
====================

The shRNA lentiviral vector used for *Nkx2--5 knockdown*
--------------------------------------------------------

The shRNA lentiviral vector GV493 was designed and made by Shanghai GeneChem. GV493 contained the following elements: hU6 (promoter), MCS (polyclonal restriction site), CBh (promoter of the enhanced green fluorescent protein \[GFP\] gcGFP gene), gcGFP gene, internal ribosomal entry site, and puromycin resistance gene. The inserted sequence used for knocking down *Nkx2--5* was TCTCAACGCCTACGGCTACAA, and the inserted sequence for the negative control was TTCTCCGAACGTGTCACGT.

Rat cardiomyocyte cells and infection by shRNA lentiviral vector
----------------------------------------------------------------

The rat cardiomyocyte cells from the H9c2(2-1) cell line were cultured with high-glucose Dulbecco's modified Eagle's medium. H9c2 cells were infected by shRNA lentiviral vector with a multiplicity of infection equal to 10. Seventy-two hours after infection, puromycin at a concentration of 0.4 μg/mL was used to kill uninfected cells.

Quantitative reverse transcription-polymerase chain reaction
------------------------------------------------------------

After the concentration of RNA from cells of the different groups was measured, the GoScript™ Reverse Transcription Mix Oligo(dT) (Promega) was used to obtain cDNA. In total, 2000 ng of RNA was used in the 20-μL reaction system. The cDNA was diluted to 40 ng/μL with nucleic acid-free water for quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Eastep^®^qPCRMaster MixKit (Promega) was used to complete the qRT-PCR for genes according to the manufacturer's instructions. All-in-One™ miRNA qRT-PCR Detection Kit (GeneCopoeia) was used to complete the qRT-PCR for miRNAs according to the manufacturer's instructions. Some qRT-PCR primers for genes were designed by Tsingke Biological Technology. Primer sequence are listed in [Table 1](#t1-medscimonit-26-e925388){ref-type="table"}. The qRT-PCR primers for miRNAs and some genes were purchased from GeneCopoeia. Due to the trade secrets involved, the sequence information cannot be provided. The protocols for qRT-PCR of mRNAs and miRNAs are listed individually in [Tables 2](#t2-medscimonit-26-e925388){ref-type="table"} and [3](#t3-medscimonit-26-e925388){ref-type="table"}. Beta-actin and U6 genes were used as internal standards. The 2^−ΔΔCt^ method was used to calculate the relative expression levels of genes, according to the cycle threshold values of the target mRNAs, miRNAs, and internal standards, respectively.

Western blot
------------

Equal amounts of protein obtained from cells in the control group and the *Nkx2--5* knockdown group were separated through 10% SDS-PAGE and transferred onto a membrane. Tris-buffered saline containing 0.1% Tween-20 (TBST) was used to dissolve 5% nonfat dry milk to block the membrane for 1 h at room temperature. The membrane was then incubated with antibodies specific for NKX2--5 (Proteintech,1: 500) and β-tubulin (Proteintech, 1: 1000) at 4°C overnight. The next day, the membrane was washed 3 times with TBST and then incubated with secondary antibody (Proteintech, 1: 2000) for 1 h at room temperature. Afterward, the membrane was again washed 3 times with TBST and substrate was added for enhanced chemiluminescence.

Cell proliferation test
-----------------------

The CCK8 method was used to detect the cells' ability to proliferate. Cells from each group were seeded into 96-well plates at the same concentration and tested every 24 h. First, we removed the old culture medium and added 100 μL of fresh culture medium and 10 μL of CCK8 solution to each well. We then continued the cell cultures for 2 h. Finally, we measured the absorbance at 450 nm with a microplate reader and constructed the CCK8 cell proliferation curve according to the numerical values.

RNA sequencing
--------------

RNA was extracted from cells using Trizol reagent (Invitrogen), and the quantity and purity of RNA were validated. A chain-specific library was constructed by removing ribosomal RNA, and this library was sequenced using Illumina Novaseq™ 6000.

The small RNA-sequencing (RNA-seq) library was completed by using the TruSeq Small RNA Sample Prep Kits (Illumina), and this library was sequenced using Illumina Hiseq2000/2500 with a single-end read length of 50 bp. R package "ballgown" was used to screen the genes with a *P*-value \<.05. TargetScan and Miranda were used to predict the target genes of miRNAs.

Statistical analysis
--------------------

The numerical results are described as the mean±standard deviation. GraphPad Prism (version 8.3.0) was used for statistical analysis and making statistical charts according to data (mean±standard deviation). The differences between the 2 groups were analyzed using *t* tests (and nonparametric tests), and *P*\<.05 indicated statistical significance.

Results
=======

Generation of *Nkx2--5* knockdown H9c2 cells
--------------------------------------------

H9c2 cells were infected with lentivirus and amplified after puromycin selection, and qRT-PCR and western blot analysis were used to validate the effect of shRNA on *Nkx2--5*. The qRT-PCR and western blot results ([Figure 1](#f1-medscimonit-26-e925388){ref-type="fig"}) indicated that the shRNA knocked down the expression of *Nkx2--5*.

Knockdown of *Nkx2--5* inhibited the proliferation of H9c2
----------------------------------------------------------

The CCK8 test was used to validate the effect of *Nkx2--5* on the proliferative capacity of H9c2 cells. The results indicated that the knockdown of *Nkx2--5* decreased the proliferative capacity of the H9c2 cells ([Figure 2](#f2-medscimonit-26-e925388){ref-type="fig"}).

Knockdown of *Nkx2--5* increased the migration of H9c2
------------------------------------------------------

The cell scratch test was used to validate the effect of *Nkx2--5* on the migration of H9c2 cells. The results indicated that the knockdown of *Nkx2--5* increased the migration ability of the H9c2 cells ([Figure 3](#f3-medscimonit-26-e925388){ref-type="fig"}).

Knockdown of *Nkx2--5* changed the transcripts
----------------------------------------------

To investigate the mechanisms leading to changes in the proliferation and migration of H9c2 cells, we used RNA-seq on the transcripts of cells. *P*-value \<0.05 was used to identify the differentially expressed genes, and the results indicated that the knockdown of *Nkx2--5* changed the expression levels of several genes. Gene Ontology (GO) enrichment analysis ([Figure 4](#f4-medscimonit-26-e925388){ref-type="fig"}) suggested that enriched genes involved the extracellular space, extracellular matrix, calcium-dependent phospholipid binding, regulation of calcium ion-dependent exocytosis, calcium ion-regulated exocytosis of neurotransmitter, cardiac epithelial to mesenchymal transition, development of the cardiac bundle of His, and cardiac muscle cell proliferation. Pathway enrichment analysis ([Figure 5](#f5-medscimonit-26-e925388){ref-type="fig"}) suggested that those genes are enriched in the transforming growth factor (TGF)-β signaling pathway, and pathways related to hypertrophic cardiomyopathy, dilated cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy.

Knockdown of *Nkx2--5* changed the expression of genes associated with proliferation
------------------------------------------------------------------------------------

The CCK8 test suggested that the knockdown of *Nkx2--5* in H9c2 cells decreased cell proliferation. To investigate the mechanism, we selected and analyzed genes associated with cell proliferation based on their FPKM values. In the *Nkx2--5* knockdown group, the results indicated that the expression of genes related to cell proliferation was changed. Among these genes, *Bche*, *Cd81*, *Col18a1*, *Crlf1*, *Ednra*, *Emp2*, *Hmga1*, *Ptk2b*, *Rxfp2*, and *Serpine2* were upregulated, and *Cenpe*, *Id2*, *Il1rl1*, *LOC100359539*, *Ndrg1*, *Nkx2--5*, *Ripor2*, *Tgfb2*, *Tnn*, and *Wt1* were downregulated. The expression of the genes is shown [Table 4](#t4-medscimonit-26-e925388){ref-type="table"}.

Knockdown of *Nkx2--5* changed the expression of genes related to migration
---------------------------------------------------------------------------

The knockdown of *Nkx2--5* was found to increase cell migration. To clarify the mechanisms, we selected and analyzed genes related to migration based on their FPKM values. In the *Nkx2--5* knockdown group, the results indicated that the expression of genes related to cell migration was changed. Among these genes, *Cemip*, *Tgfb2*, and *Tnn* were downregulated, and *Aqp1*, *Col18a1*, *Efna1*, *Emp2*, *Itga7*, *Lcp1*, *Ptk2b*, and *S1pr1* were upregulated. The expression of the genes is shown in [Table 5](#t5-medscimonit-26-e925388){ref-type="table"}.

Knockdown of *Nkx2--5* changed the expression of genes associated with cardiovascular morphogenesis, cardiovascular function, and disease
-----------------------------------------------------------------------------------------------------------------------------------------

To clarify the functional mechanisms of NKX2--5 in the heart, we selected and analyzed genes associated with cardiovascular morphogenesis, function, and disease based on their FPKM values. In the *Nkx2--5* knockdown group, the results indicated that the expression of *Cited1*, *Id2*, *Lrp2*, *Olfm1*, *Olfm2*, *Pou5f1*, *Serpina3c*, *Tgfb2*, *Wnt4*, *Wt1*, and *Xdh* was downregulated, while the expression of *Aqp1*, *Cacna1g*, *Chrd*, *Dcn*, *Ednra*, *Efna1*, *Eln*, *Emp2*, *Heyl*, *Myo7a*, *Nalcn*, *Ptk2b*, *Rap1gap*, *Ren*, *S1pr1*, *Tenm4*, and *Thbs2* was upregulated. The expression of the genes is shown [Table 6](#t6-medscimonit-26-e925388){ref-type="table"}.

Knockdown of *Nkx2--5* changed the expression of miRNAs
-------------------------------------------------------

To clarify the function of miRNAs in the heart, we used a *P*-value \<.05, rat species, and an miRbase database to screen for differentially expressed miRNAs. The miRNAs selected through this process are depicted in the heat map shown in [Figure 6](#f6-medscimonit-26-e925388){ref-type="fig"}. The miRNAs are listed in [Table 7](#t7-medscimonit-26-e925388){ref-type="table"}. The target genes of the miRNAs were analyzed after prediction, and GO analysis ([Figure 7](#f7-medscimonit-26-e925388){ref-type="fig"}) indicated that they are related to transcriptional regulation, redox, signal transduction, apoptosis, cell differentiation, cell proliferation, protein phosphorylation, proteolysis, intracellular signal transduction, protein ubiquitin, gene expression, protein binding, metal ion binding, ATP binding, homologous protein binding, homologous domain protein dimerization body activity, DNA binding, RNA binding, zinc ion binding, and calcium ion binding. Pathway enrichment analysis ([Figure 8](#f8-medscimonit-26-e925388){ref-type="fig"}) suggested that the target genes are enriched in the MAPK signaling pathway and other signaling pathways.

Validation of RNA-seq
---------------------

We used qRT-PCR to validate the RNA-seq results. The results from the *Nkx2--5* knockdown group ([Figures 9](#f9-medscimonit-26-e925388){ref-type="fig"}, [10](#f10-medscimonit-26-e925388){ref-type="fig"}) showed that the expression of *Tgfb-2* (0.62±0.03), *Wnt4* (0.56±0.19), *Xdh* (0.70±0.12), *Lrp2* (0.69±0.12), *Cited1* (0.64±0.28), *Syt1* (0.78±0.16), *Emp2* (0.15±0.06), *Pou5f* (0.75±0.11), *Itga7* (0.89±0.04), rno-miR-1-3p (0.14±0.04), rno-let-7a-5p (0.73±0.13), rno-miR-148b-3p (0.32±0.03), rno-miR-361-3p (0.09±0.01), and rno-miR-25-3p(0.45±0.03) was downregulated, and the expression of *Id2* (1.58±0.16), *Cacna1g* (1.64±0.41), *Wt1* (5.22±1.57), *Hey1* (3.01±1.62), *Olfml* (2.65±0.31), *Slrp1* (2.30±0.33), *Nectin3* (1.80±0.27), *Tenm4* (2.51±0.82), *Bmp10* (35.62±3.18), rno-miR-1-5p (1.31±0.09), rno-miR-149-5p (1.37±0.22), and rno-miR-455-3p (1.72±0.28) was upregulated.

Discussion
==========

In this study, we found that *Nkx2--5* regulates the proliferation and migration of H9c2 cells, as well as the expression of genes associated with proliferation, migration, heart development, and heart disease. Bioinformatics analysis suggested that the genes that were differentially expressed following knockdown of *Nkx2--5* are enriched in cardiac development, calcium ion-related biological activity, the TGF-β signaling pathway, pathways related to heart diseases, the MAPK signaling pathway, and other biological processes and signaling pathways.

Cardiac development includes the proliferation, migration, and differentiation of heart precursor cells \[[@b21-medscimonit-26-e925388],[@b22-medscimonit-26-e925388]\]. Cardiac development starts on both sides of the front of the mesoderm, with cells from the heart-forming regions migrating and forming the heart tube \[[@b21-medscimonit-26-e925388],[@b22-medscimonit-26-e925388]\]. The heart tube subsequently twists and cyclizes into a 3-dimensional heart structure \[[@b21-medscimonit-26-e925388],[@b22-medscimonit-26-e925388]\]. With the differentiation of cardiac precursor cells, the heart gradually achieves contraction and relaxation related to the pumping function \[[@b23-medscimonit-26-e925388]\]. Therefore, the proliferation, migration, and differentiation of the heart precursor cells are necessary for cardiac morphogenesis and function. In a previous study, the knockout of *Nkx2--5* in mice resulted in abnormal heart development, growth arrest, and embryo death \[[@b24-medscimonit-26-e925388]\]. Histological examination revealed that the structure of the heart tube occurred normally, but the heart tube failed to twist and form the 3-dimensional heart structure \[[@b24-medscimonit-26-e925388]\]. In our study, the knockdown of *Nkx2--5* in H9c2 rat cardiomyocytes changed cell proliferation and migration, as well as gene expression. The results from qRT-PCR showed that in the *Nkx2--5* knockdown group, the expression of *Tgfb-2*, *Wnt4*, *Xdh*, *Lrp2*, *Cited1*, *Syt1*, *Emp2*, *Pou5f*, *Itga7*, rno-miR-1-3p, rno-let-7a-5p, rno-miR-148b-3p, rno-miR-361-3p, and rno-miR-25-3p was downregulated, and the expression of *Id2*, *Cacna1g*, *Wt1*, *Hey1*, *Olfml*, *Slrp1*, *Nectin3*, *Tenm4*, *Bmp10*, rno-miR-1-5p, rno-miR-149-5p, and rno-miR-455-3p was upregulated. Among the genes with altered expression, *Tgfb-2*, *Bmp10*, *Id2*, *Wt1*, *Hey1*, *Cacna1g*, and miR-1-3p are associated with cardiac morphogenesis and function.

TGF-β2 has functions in many biological activities \[[@b25-medscimonit-26-e925388]\]. Mice with dysfunction of TGF-β2 have been shown to have developmental defects of multiple organs leading to death at birth \[[@b26-medscimonit-26-e925388]\]. In addition, TGF-β2-deficient mice were found to develop outflow tract malformations, permanent arterial trunks, membrane peripheral VSD, aortic valve hypertrophy, tricuspid valve deformity, and complete atrioventricular septal defect \[[@b27-medscimonit-26-e925388]\]. These findings suggest that the disruption of TGF-β2 results in the incomplete twisting of the heart tube and abnormal development of the atrioventricular septum \[[@b27-medscimonit-26-e925388]\]. In our study, we found that *Nkx2--5* knockdown changed the expression of *Tgf-*β*2* and *Bmp10*. Further, our bioinformatics analysis indicated that the TGF-β signaling pathway was enriched. Together, these results suggest that NKX2--5 affects the TGF-β signaling pathway through *Tgf-*β*2*, *Bmp10*, and other genes and thereby influences the regulation of cardiac development.

*Id2* is expressed in endocardial pads, inflow tracts, outflow tracts, and developing heart valves \[[@b28-medscimonit-26-e925388],[@b29-medscimonit-26-e925388]\], as well as in the cardiac neural crest \[[@b29-medscimonit-26-e925388],[@b30-medscimonit-26-e925388]\]. The Id protein functions in myogenesis \[[@b31-medscimonit-26-e925388]\] and in cell growth, differentiation, and neurogenesis \[[@b32-medscimonit-26-e925388]\]. The disruption of *Id2* results in defects in the structures related to the cardiac neural crest \[[@b29-medscimonit-26-e925388],[@b30-medscimonit-26-e925388]\]. In our study, we found that *Nkx2--5* knockdown changed the expression of *Id2*, which was similar to results reported by Lim et al. \[[@b33-medscimonit-26-e925388]\]. Therefore, we suggest that NKX2--5 regulates the formation of the structures related to the cardiac neural crest through *Id2*.

*Wt1* functions in the epicardial epithelial-mesenchymal transition (EMT) process through *Snai1* and *Cdh1* \[[@b34-medscimonit-26-e925388]\]. The epicardial EMT process is thought to be involved in the development of the heart \[[@b34-medscimonit-26-e925388],[@b35-medscimonit-26-e925388]\]. Knockout of *Wt1* resulted in decreased proliferation of dense myocardial cells, abnormal coronary artery formation, defects in the EMT process, and abnormal activation of the Wnt signaling pathway \[[@b34-medscimonit-26-e925388],[@b36-medscimonit-26-e925388]\]. In the present study, the knockdown of *Nkx2--5* in H9c2 cells changed the expression of *Wt1*, suggesting that NKX2--5 may regulate the epicardial EMT process through *Wt1*.

*Hey1* belongs to the *Hey* gene family \[[@b37-medscimonit-26-e925388]\], which includes *Hey1*, *Hey2*, and *HeyL* \[[@b38-medscimonit-26-e925388],[@b39-medscimonit-26-e925388]\]. *Hey1* is expressed in the endocardial layer of the atrioventricular tube, which forms the membranous septum and valves of the heart \[[@b39-medscimonit-26-e925388]\]. Previously, knockout of *Hey1* and *HeyL* was shown to damage the endocardial EMT process and result in VSD and dysplastic valves \[[@b39-medscimonit-26-e925388],[@b40-medscimonit-26-e925388]\]. The knockdown of *Nkx2--5* in H9c2 cells in the current study changed the expression of *Hey1*, suggesting that NKX2--5 may regulate the morphogenesis of the membranous septum and valves of the heart through *Hey1*.

Human *CACNA1G*, which is homologous to rat *Cacna1g*, is also called *Cav3.1*. Cav3.1 participates in the heart's electrophysiological activities \[[@b41-medscimonit-26-e925388],[@b42-medscimonit-26-e925388]\]. After myocardial infarction in mice, knocking down Cav3.1 decreased the myocardial contractile function and increased the cardiac rhythm variation \[[@b43-medscimonit-26-e925388]\]. In our study, the knockdown of *Nkx2--5* changed the expression of *Cacna1g*, suggesting that NKX2--5 may regulate cardiac electrophysiological activity through *Cacna1g*.

miRNA1 functions in the heart \[[@b44-medscimonit-26-e925388],[@b45-medscimonit-26-e925388]\]. Previously, the knockout of miRNA1 resulted in a lack of the characteristic striped appearance in the mouse myocardium, and knockdown of miRNA1 resulted in VSD and cardiac dysfunction \[[@b46-medscimonit-26-e925388]\]. In our study, the knockdown of *Nkx2--5* altered the expression of rno-miR-1-3, suggesting that NKX2--5 may regulate cardiac development and function through miRNA1.

Conclusions
===========

*Nkx2--5* regulates cell proliferation and migration and the expression of genes associated with proliferation, migration, heart development, and disease in H9c2 cells. Genes associated with these activities include *Tgfb-2*, *Id2*, *Ptk2b*, *Cacna1g*, *Wt1*, *Heyl*, *Olfml*, *Wnt4*, *Xdh*, *Lrp2*, *Cited1*, *Syt1*, *Emp2*, *Pou5f*, *Syt13*, *Itga7*, *Fos*, *Slrp1*, *Nectin3*, *Tenm4*, *Bmp10*, rno-miR-1-5p, rno-miR-1-3p, rno-let-7a-5p, rno-miR-148b-3p, rno-miR-149-5p, rno-miR-361-3p, rno-miR-455-3p, and rno-miR-25-3p. Bioinformatics analysis suggested that genes that were differentially expressed because of *Nkx2--5* knockdown are enriched in cardiac development, calcium ion-related biological activity, the TGF-β signaling pathway, pathways related to heart diseases, the MAPK signaling pathway, and other biological processes and signaling pathways.

**Conflict of interest**

None

**Source of support:** This work was supported by grants from National Natural Science Foundation of China (No. 81560060, 31160230, 81760059), Project of "YUN LING Scholar," and Yunnan/Kunming Key Laboratory of Cardiovascular Surgery

![Verification of the knockdown effect of shRNA lentivirus on *Nkx2--5* in H9c2 cells by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and western blot analysis, respectively. (**A**) qRT-PCR detection of the expression of *Nkx2--5* in the control group and the *Nkx2--5* knockdown group. (**B**) Western blot detection of the expression of *Nkx2--5* in the control group and the *Nkx2--5* knockdown group.](medscimonit-26-e925388-g001){#f1-medscimonit-26-e925388}

![Knockdown of *Nkx2--5* inhibited the proliferative capacity of H9c2 cells. The CCK8 method was used to detect the effect of *Nkx2--5* on the proliferative capacity of H9c2 cells. (**A**) Cell growth was detected with the CCK8 method for 4 consecutive days. (**B**) Statistics of the CCK8 curve are shown.](medscimonit-26-e925388-g002){#f2-medscimonit-26-e925388}

![Knockdown of *Nkx2--5* increase the migration ability of H9c2 cells. The cell scratch test was used to detect the effect of *Nkx2--5* on the migration ability of H9c2 cells (0--72 h). Cells were seeded in the culture-insert, which was removed after 24 h, and cells were then continuously observed for 72 h.](medscimonit-26-e925388-g003){#f3-medscimonit-26-e925388}

![Gene Ontology (GO) analysis of the differential expression of genes caused by knockdown of *Nkx2--5* indicated that the genes are enriched in many biological processes, including cardiac epithelial to mesenchymal transition, development of the cardiac bundle of His, and cardiac muscle cell proliferation.](medscimonit-26-e925388-g004){#f4-medscimonit-26-e925388}

![Pathway analysis of the differential expression of genes caused by knockdown of *Nkx2--5* indicated that the genes are enriched in the transforming growth factor (TGF)-β signaling pathway, and pathways related to hypertrophic cardiomyopathy, dilated cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy.](medscimonit-26-e925388-g005){#f5-medscimonit-26-e925388}

![Heat map of the differentially expressed miRNAs following knockdown of *Nkx2--5*.](medscimonit-26-e925388-g006){#f6-medscimonit-26-e925388}

![Gene Ontology (GO) enrichment analysis of the target genes of the differentially expressed miRNAs caused by knockdown of *Nkx2--5* indicated that those genes function in many biological processes.](medscimonit-26-e925388-g007){#f7-medscimonit-26-e925388}

![Pathway enrichment analysis of the target genes of miRNAs that were differentially expressed owing to knockdown of *Nkx2--5* indicated that the target genes are enriched in the MAPK signaling pathway and other signaling pathways.](medscimonit-26-e925388-g008){#f8-medscimonit-26-e925388}

![(**A--D**) Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis of the relative expression levels of *Tgfb-2*, *Id2*, *Ptk2b*, *Cacna1g*, *Wt1*, *Heyl*, *Olfml*, *Wnt4*, *Xdh*, *Lrp2*, *Cited1*, *Syt1*, *Emp2*, and *Pou5f* in the control group and in the *Nkx2--5* knockdown group. The expression level of the genes in the control group was calculated as 1. The bar represents the fold change of the genes in the *Nkx2--5* knockdown group compared with the control group. \* *P*\<.05; \*\* *P*\<.01; \*\*\* *P*\<.001; \*\*\*\* *P*\<.0001.](medscimonit-26-e925388-g009){#f9-medscimonit-26-e925388}

![(**A--D**) Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis of the relative expression levels of *Syt13*, *Itga7*, *Fos*, *Slrp1*, *Nectin3*, *Tenm4*, *Bmp10*, rno-miR-1-5p, rno-miR-1-3p, rno-let-7a-5p, rno-miR-148b-3p, rno-miR-149-5p, rno-miR-361-3p, rno-miR-455-3p, and rno-miR-25-3p in the control group and in the *Nkx2--5* knockdown group. The expression level of the genes in the control group was calculated as 1. The bar represents the fold change of the genes in the *Nkx2--5* knockdown group compared with the control group. \* *P*\<.05; \*\* *P*\<.01; \*\*\* *P*\<.001; \*\*\*\* *P*\<.0001.](medscimonit-26-e925388-g010){#f10-medscimonit-26-e925388}

###### 

Sequence information of all quantitative reverse transcription-polymerase chain reaction (qRT-PCR) primers.

  Genes            Sequence of prime          Tm
  ---------------- -------------------------- --------
  *Nkx2--5*-F      GTAAGCGACAGCGGCAGGAC       58.7°
  *Nkx2--5*-R      CGACGCCAAAGTTCACGAAG       58.7°
  *Beta-actin*-F   TGAGAGGGAAATCGTGCGTGAC     53.9°C
  *Beta-actin*-R   ATCTGCTGGAAGGTGGACAGTGAG   53.9°C
  *Cacna1g*-F      GACCAAACAGCGGGAGAGTC       60.27
  *Cacna1g*-R      CTGCCCACTACGGGCCAC         62.78
  *Cited1*-F       GCCACCCCTTCTACCAAACC       60.61
  *Cited1*-R       GATCCCAGTGCCCCAGTTTA       59.38
  *Emp2*-F         GACAATGCCTGGTGGGTAGG       60.39
  *Emp2*-R         ATAGACGGAAGCCCCGATCA       60.47
  *Fos*-F          GGAGGGAGCTGACAGATACG       59.33
  *Fos*-R          CAGACCCCCAGTCAAGTCCA       60.13
  *Heyl*-F         CTCTTCTCCCCCTTACCCGA       60.03
  *Heyl*-R         ACCAGACGCACTGTCATCAG       60.04
  *Id2*-F          GGTCCGTTAGGAAAAACAGCC      60.5
  *Id2*-R          CTGACGATAGTGGGGTGCGAG      62.8
  *Itga7*-F        CATGGATCTGGATGGGACCG       59.96
  *Itga7*-R        AGGCATTCTCGTTGGACAGG       60.04
  *Nectin3*-F      ATCGCTGTCTTTGTGACTGTG      58.86
  *Nectin3*-R      TGAGTCCCATCTTCTTGCACT      59.02
  *Olfm1*-F        CAAACCAGAACGCAGGCAAC       60.59
  *Olfm1*-R        CGAGGCGTTGGTTTGGTAGG       61.3
  *Pou5f1*-F       TGGCTTCAGACTTCGCCTTC       60.32
  *Pou5f1*-R       GATCCCCAGCACCTCTGAAC       60.11
  *Ptk2b*-F        TTGACCACCCTCACATCGTC       59.68
  *Ptk2b*-R        GAGCGTACAGGACCAGAGTG       59.83
  *S1pr1*-F        CCCAGTGGTTAAGGCTCTCC       59.75
  *S1pr1*-R        CTGTGTAAGCCACTCCTGCT       59.68
  *Syt1*-F         GGATGACGATGCTGAAACCG       59.35
  *Syt1*-R         TCTTTTTGTCAGGCAGCAGGA      60.13
  *Syt13*-F        TTCATCCTCCCTCAGAACGGT      60.8
  *Syt13*-R        GGTCATAGTCCAGGCGAAAGTG     61.2
  *Tenm4*-F        TGTGGATGTGGAAGAGCGTG       60.32
  *Tenm4*-R        CCCAGTCCCAGTTCTCGAAG       59.75
  *Tgfb2*-F        TTGGATGCCGCCTATTGCTT       60.4
  *Tgfb2*-R        TACAGGCTGAGGACTTTGGTG      59.65
  *Wnt4*-F         CTCGTCTTCGCCGTGTTCTC       61.07
  *Wnt4*-R         GCACTGAGTCCATCACCTCG       60.46
  *Wt1*-F          CTTCTCCGGCCAGTTCACC        60.38
  *Wt1*-R          TATCCTTGGTTGCGGATGGAG      59.86
  *Xdh*-F          CTGTTGACCCATGGAGGGAC       60.04
  *Xdh*-R          CGTATAGGCGTCCATCACCC       60.04

###### 

The protocol of quantitative reverse transcription-polymerase chain reaction (qRT-PCR) of mRNAs.

                            Temperature   Times     Cycle
  ------------------------- ------------- --------- -----------
  **Amplification stage**                           
  Pre-denature              95°C          2 min     1 cycle
  Amplification             95°C          15 s      40 cycles
  60°C                      50 s                    
  **Dissociation stage**                            
  Melting curves            95°C          5 s       1 cycle
  65°C                      5 s           1 cycle   
  95°C                      Hold          1 cycle   

###### 

The protocol of quantitative reverse transcription-polymerase chain reaction (qRT-PCR) of miRNAs.

                            Temperature             Times            Cycle
  ------------------------- ----------------------- ---------------- -----------------
  **Amplification stage**                                            
  Pre-denature              95°C                    10 min           1 cycle
  Denature                  95°C                    10 s             
  Amplification             Tm-2°C                  20 s             40 cycles
  72°C                      10 s                                     
                            **Temperature range**   **Heat ratio**   **Temperature**
  **Dissociation stage**                                             
  Melting curves            65--95°C                0.5°C/time       6 s/time
  30°C                                              30 s             

###### 

The expression level of the differentially expressed genes related to cell proliferation according to FPKM value.

  Gene name        Up/down   Knock-down group   Control group   Fold change   P-value
  ---------------- --------- ------------------ --------------- ------------- -------------
  *Bche*           Up        0.354186667        0.127371333     2.780740826   0.028197175
  *Cd81*           Up        3.180889           1.060321333     2.999929267   0.037666133
  *Col18a1*        Up        1.622587377        0.805795694     2.013646124   0.037666133
  *Crlf1*          Up        1.371389526        0.381314621     3.596477685   0.037666133
  *Ednra*          Up        7.472959951        2.16629906      3.449643722   0.037666133
  *Emp2*           Up        0.398951333        0.114417        3.486818684   0.037666133
  *Hmga1*          Up        11.72277317        5.04543594      2.323441088   0.028197175
  *Ptk2b*          Up        1.624791991        0.688358574     2.360386072   0.037666133
  *Rxfp2*          Up        0.95118            0.338642        2.808806941   0.028197175
  *Serpine2*       Up        14.57077164        7.18728464      2.027298537   0.028197175
  *Cenpe*          Down      2.752010696        5.505788696     0.498510584   0.043675528
  *Id2*            Down      2.615604826        6.236435442     0.435260138   0.035903501
  *Il1rl1*         Down      1.041805031        2.359768185     0.475813274   0.028197175
  *LOC100359539*   Down      16.170679          46.241846       0.34092758    0.037666133
  *Ndrg1*          Down      0.058952144        0.581966619     0.131365005   0.028197175
  *Nkx2--5*        Down      0.811241           1.914524333     0.40684553    0.037666133
  *Ripor2*         Down      0.862623412        4.835583656     0.141300869   0.035903501
  *Tgfb2*          Down      10.51144076        22.92765142     0.468730695   0.02243198
  *Tnn*            Down      0.975868592        2.531033413     0.378168426   0.02243198
  *Wt1*            Down      0.1274315          0.345506667     0.367150658   0.028197175

###### 

The expression level of the differentially expressed genes related to cell migration according to FPKM value.

  Gene name   Up/down   Knock-down group   Control group   Fold change   P-value
  ----------- --------- ------------------ --------------- ------------- -------------
  *Cemip*     Down      0.299191667        0.636106333     0.470348511   0.028361462
  *Tgfb2*     Down      10.74689399        22.92765142     0.468730695   0.028361462
  *Tnn*       Down      0.957156921        2.531033413     0.378168426   0.011414219
  *Aqp1*      Up        12.23365337        2.509491509     4.874953084   0.028361462
  *Col18a1*   Up        1.622587377        0.805795694     2.013646124   0.028361462
  *Efna1*     Up        7.933838           3.165927        2.506007877   0.011414219
  *Emp2*      Up        0.398951333        0.114417        3.486818684   0.011414219
  *Itga7*     Up        35.6172742         15.57743844     2.286465412   0.011414219
  *Lcp1*      Up        0.530143013        0.17685835      2.997557156   0.011414219
  *Ptk2b*     Up        1.624791991        0.688358574     2.360386072   0.028361462
  *S1pr1*     Up        0.402147           0.115644        3.477456677   0.011414219

###### 

The expression level of the differentially expressed genes related to cardiovascular development, function and disease according to FPKM value.

  Gene name     Up/down   Knock-down group   Control group   Fold change   P-value
  ------------- --------- ------------------ --------------- ------------- -------------
  *Cited1*      Down      0.137443766        0.688688943     0.199573069   0.032938043
  *Id2*         Down      2.714471751        6.236435442     0.435260138   0.000365474
  *Lrp2*        Down      0.017384           0.059996333     0.28975104    0.003245192
  *Nkx2--5*     Down      0.778915667        1.914524333     0.40684553    0.006318441
  *Olfm1*       Down      0.128097341        0.290353507     0.441177177   0.000208684
  *Olfm2*       Down      1.721408393        3.702179558     0.464971611   0.011101623
  *Pou5f1*      Down      0.308853095        0.694788528     0.444528202   0.011101623
  *Serpina3c*   Down      1.586827           3.243215667     0.489275819   0.009289732
  *Tgfb2*       Down      10.74689399        22.92765142     0.468730695   0.000208684
  *Wnt4*        Down      1.074377465        3.383843595     0.317502105   0.002484204
  *Wt1*         Down      0.126853           0.345506667     0.367150658   0.002484204
  *Xdh*         Down      6.73928628         14.19602639     0.47473047    0.011101623
  *Aqp1*        Up        12.23365337        2.509491509     4.874953084   0.02208052
  *Cacna1g*     Up        2.314802229        0.980096727     2.361809977   0.006318441
  *Chrd*        Up        2.940675           1.427321333     2.060275378   0.011101623
  *Dcn*         Up        11.71709687        5.777820047     2.027944238   0.009289732
  *Ednra*       Up        7.472959951        2.16629906      3.449643722   0.006318441
  *Efna1*       Up        7.933838           3.165927        2.506007877   0.02208052
  *Eln*         Up        4.81633855         0.152180345     31.64888704   0.038387993
  *Emp2*        Up        0.398951333        0.114417        3.486818684   0.005207576
  *Heyl*        Up        0.220188667        0.104787        2.101297553   0.000208684
  *Myo7a*       Up        13.55489722        5.230017929     2.591749666   0.011101623
  *Nalcn*       Up        1.496093741        0.738173261     2.026751469   0.035903501
  *Ptk2b*       Up        1.624791991        0.688358574     2.360386072   0.005207576
  *Rap1gap*     Up        3.104311744        0.954441805     3.252489287   0.011101623
  *Ren*         Up        0.471765676        0.090147279     5.233276913   0.032938043
  *S1pr1*       Up        0.402147           0.115644        3.477456677   0.011101623
  *Tenm4*       Up        0.426035667        0.071534        5.955708707   0.000556863
  *Thbs2*       Up        2.631674667        0.831391667     3.165384947   0.009289732

###### 

The expression level of the differentially expressed miRNAs.

  miRNA name        Up/down   Knock-down group   Control group   Fold change   P-value
  ----------------- --------- ------------------ --------------- ------------- -------------
  rno-let-7c-5p     Up        48915.11106        30241.59174     1.617478057   0.000585036
  rno-miR-148b-3p   Up        13050.37614        8878.710132     1.469850456   0.004440698
  rno-miR-34c-5p    Up        78966.93058        57614.25952     1.370614345   0.012571048
  rno-let-7a-5p     Up        47559.38952        34788.86768     1.367086447   0.00358211
  rno-miR-25-3p     Up        57776.68845        42623.04547     1.355526988   0.033953322
  rno-miR-152-3p    Up        42183.6253         31396.35416     1.34358356    0.022837988
  rno-miR-28-3p     Up        30385.28687        22978.91272     1.322311775   0.02820609
  rno-let-7g-5p     Up        34278.14567        27082.60381     1.265688702   0.046242269
  rno-let-7b-5p     Up        124070.9522        103767.0116     1.195668549   0.046844482
  rno-let-7c-5p     Up        48915.11106        30241.59174     1.617478057   0.000585036
  rno-miR-361-3p    Down      7844.3994          10147.88957     0.773007958   0.032547771
  rno-miR-149-5p    Down      35717.84765        51835.03885     0.689067635   0.007257529
  rno-miR-501-3p    Down      8354.323719        12609.30375     0.662552341   0.023377351
  rno-miR-423-3p    Down      45506.30495        73698.63424     0.617464698   0.004694093
  rno-miR-455-3p    Down      22803.13515        38129.14689     0.59804997    0.000814365
  rno-let-7d-3p     Down      74365.97971        124461.4958     0.597501896   0.000455668
  rno-miR-328a-3p   Down      15499.58264        28493.79288     0.543963477   0.001862949
  rno-miR-296-5p    Down      6382.826735        12088.66725     0.528000863   0.004167743
  rno-miR-484       Down      4410.345009        8941.350383     0.493252677   0.019675131
  rno-miR-486       Down      17019.31937        55793.9353      0.305038877   0.000505176
  rno-miR-1-3p      Down      56.20631293        64.31886677     0.873869764   0.049593776

[^1]: Study Design

[^2]: Data Collection

[^3]: Statistical Analysis

[^4]: Data Interpretation

[^5]: Manuscript Preparation

[^6]: Literature Search

[^7]: Funds Collection

[^8]: Hongshu Wang and Yong Liu are co-first Authors
